Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two daily pill options and long-acting injections effectively prevent HIV.
PrEP plus HIV screening every three months would lead to fewer new cases, longer life expectancy and lower HIV-associated costs.
Under a new federal policy, Medicare will cover PrEP pills and injections for people age 65 and older.
Celebrating healthy, pleasurable and responsible sexual relationships—including PrEP to prevent HIV—is for “every BODY.”
About 94% of white people who could benefit from PrEP have been prescribed it, but only 13% of Black and 24% of Latino people have been.
Providing a course of antiretrovirals to use after infrequent HIV exposures could lower cost and remove barriers to access.
#NLAAD celebrates 20 years of Latino AIDS education on Sunday, October 15. This year’s theme focuses on various ways to prevent HIV.
Armando Herrera sold adulterated and misbranded HIV drugs through companies in six states. He faces a maximum of five years in prison.
When given a choice, most women chose injectable cabotegravir over daily prevention pills.
Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.
There are now three FDA-approved PrEP medications in the United States—two are pills, and one is a shot.
Findings suggest that daily oral PrEP or long-acting injectables might be better options for young men who have spontaneous sex.
Internal documents show Gilead held off on developing new therapies, such as Descovy, a potentially less toxic version of Truvada.
Eleven years ago, Truvada became the first medication approved for HIV prevention. Today, disparities in PrEP coverage still exist.
The $3.6 billion antitrust court case cleared Gilead Sciences and Teva of delaying the release of generic Truvada and other HIV meds.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.